The DOI matches its Crossref record.
Systemic Fungal Infections Caused by Candida Species: Epidemiology, Infection Process and Virulence Attributes
Abstract
Candida species, in particular C. albicans, represent a major threat to immunocompromised patients. Able to exist as a commensal on mucosal surfaces of healthy individuals, these opportunistic fungi frequently cause superficial infections of mucosae and skin. Furthermore, in hospital settings, Candida species may cause life-threatening invasive infections in a growing population of vulnerable patients. In fact, candidaemia is associated with the highest crude mortality of all bloodstream infections. Candida cells may enter the bloodstream by direct penetration from epithelial tissues, due to damage of barriers in the body caused by surgery, polytrauma or drug treatment, or may spread from biofilms produced on medical devices. From the bloodstream, cells may infect almost all organs but appear to prefer certain organs depending upon the route of infection. The exact mechanisms by which Candida cells survive the challenge of the blood environment and escape from the bloodstream to cause deep-seated infections have not yet been elucidated, but various investigations are reviewed. It is clear, however, that Candida must have particular attributes which enable the organism to survive and grow within the environment of healthy individuals and to invade tissues in the immunocompromised host. Most studies have focussed on C. albicans and this review will therefore summarise work on the various known virulence factors and methods used to identify further virulence attributes of this fungus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is noteworthy, however, that during dissemination, fungi are likely exposed only briefly to the bloodstream before they enter the target organs and hence that early survival may be crucial for successful systemic infections (71).”
From A novel hybrid iron regulation network combines features from pathogenic and nonpathogenic yeasts (2016) · cites this paper as [71]
Citations
Cited by
Sorted by citations
Items 101–200 of 252
Corneal Virulence of Candida albicans Strains Deficient in Tup1-Regulated Genes
Jackson, B. E., Mitchell, B. M., & Wilhelmus, K. R. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0909 · Cited by 26
Subversion strategies of lysosomal killing by intracellular pathogens
Teixeira, S. C., Teixeira, T. L., Tavares, P. C. B., Alves, R. N., da Silva, A. A., Borges, B. C., Martins, F. A., dos Santos, M. A., de Castilhos, P., Brígido, R. T. E. S., et al. (2023) · Microbiological Research · doi:10.1016/j.micres.2023.127503 · Cited by 23
West, P. T., Peters, S. L., Olm, M. R., Yu, F. B., Gause, H., Lou, Y. C., Firek, B., Baker, R. W., Johnson, A. D., Morowitz, M. J., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01085-y · Cited by 25
Candida theae sp. nov., a new anamorphic beverage-associated member of the Lodderomyces clade
Chang, C., Lin, Y., Chen, S.-F., et al. (2011) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2011.09.012 · Cited by 24
Human laminin‐332 degradation by Candida proteinases
Pärnänen, P., Kari, K., Virtanen, I., Sorsa, T., & Meurman, J. H. (2008) · Journal of Oral Pathology & Medicine · doi:10.1111/j.1600-0714.2008.00638.x · Cited by 24
Kozik, A., Gogól, M., Bocheńska, O., Karkowska-Kuleta, J., Wolak, N., Kamysz, W., Aoki, W., Ueda, M., Faussner, A., & Rapała-Kozik, M. (2015) · BMC Microbiology · doi:10.1186/s12866-015-0394-8 · Cited by 24
“systemic diseases with high mortality rates [9].”
BackgroundHadžić, S., Dedić, A., GojkovVukelic, M., et al. (2013) · Materia Socio Medica · doi:10.5455/msm.2013.25.223-225 · Cited by 23
Bellotti, D., Tocchio, C., Guerrini, R., Rowińska‐Żyrek, M., & Remelli, M. (2019) · Metallomics · doi:10.1039/c9mt00251k · Cited by 22
Rąpała‐Kozik, M., Surowiec, M., Juszczak, M., Wronowska, E., Kulig, K., Bednarek, A., Gonzalez‐Gonzalez, M., Karkowska‐Kuleta, J., Zawrotniak, M., Satała, D., et al. (2023) · Yeast · doi:10.1002/yea.3855 · Cited by 24
Candida albicans zincophore and zinc transporter interactions with Zn( ii ) and Ni( ii )
Łoboda, D., & Rowińska‐Żyrek, M. (2018) · Dalton Transactions · doi:10.1039/c7dt04403h · Cited by 22
Assessing the advantage of morphological changes in Candida albicans: a game theoretical study
Tyc, K. M., Kühn, C., Wilson, D., & Klipp, E. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00041 · Cited by 22
“Additionally, immunocompromised patients are especially susceptible to fungal infections (Mavor et al., 2005).”
BackgroundInfluentialBiocontrol of Candida albicans by Antagonistic Microorganisms and Bioactive Compounds
Li, H., Yang, J., Zhang, X., Xu, X., Song, F., & Li, H. (2022) · Antibiotics · doi:10.3390/antibiotics11091238 · Cited by 22
Lindnera (Pichia) fabianiiblood infection after mesenteric ischemia
Gabriel, F., Noël, T., & Accoceberry, I. (2012) · Medical Mycology · doi:10.3109/13693786.2011.587455 · Cited by 21
In vitroeffect of DNA topoisomerase inhibitors onCandida albicans
Kwok, C. S., Schelenz, S., Wang, X., & Steverding, D. (2010) · Medical Mycology · doi:10.3109/13693780903114934 · Cited by 20
Febrile neutropenia in children with acute lymphoblastic leukemia: single center experience
Özdemir, N., Tüysüz, G., Çelik, N., Yantri, L., Erginöz, E., Apak, H., Özkan, A., Yıldız, İ., & Celkan, T. T. (2016) · Türk Pediatri Arşivi · doi:10.5152/turkpediatriars.2016.2757 · Cited by 22
Bocheńska, O., Rąpała‐Kozik, M., Wolak, N., Kamysz, W., Grzywacz, D., Aoki, W., Ueda, M., & Kozik, A. (2015) · Biological Chemistry · doi:10.1515/hsz-2015-0167 · Cited by 20
Khan, S., Cai, L., Bilal, H., Khan, M. N., Fang, W., Zhang, D., Yao, F., Wang, X., Wang, Q., Hou, B., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-92100-x · Cited by 19
“The prevalence of Candida species on the skin of the hands and the ability to transfer to catheters are widely recognized 71,72 .”
Nectriatide, a Potentiator of Amphotericin B Activity from Nectriaceae sp. BF-0114
Fukuda, T., Nagai, K., Yagi, A., Kobayashi, K., Uchida, R., Yasuhara, T., & Tomoda, H. (2019) · Journal of Natural Products · doi:10.1021/acs.jnatprod.8b01056 · Cited by 20
Jakab, Á., Mogavero, S., Förster, T. M., Pekmezovic, M. G., Jablonowski, N., Dombrádi, V., Pócsi, I., & Hube, B. (2016) · Microbiology · doi:10.1099/mic.0.000383 · Cited by 18
Self-citationLohith, K., & Anu‐Appaiah, K. A. (2017) · Medical Mycology · doi:10.1093/mmy/myx156 · Cited by 19
Silymarin, a Popular Dietary Supplement Shows Anti–Candida Activity
Janeczko, M., & Kochanowicz, E. (2019) · Antibiotics · doi:10.3390/antibiotics8040206 · Cited by 19
“albicans secrete phospholipases from four different classes (A–D), but only five members of class B (PLB1-5) are extracellular and contribute to pathogenicity [23].”
BackgroundGyetvai, Á., Emri, T., Fekete, A., Varga, Z., Gazdag, Z., Pesti, M., Belágyi, J. Z., Emödy, L., Pócsi, I., & Lenkey, B. (2006) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2006.00179.x · Cited by 19
The Dynamics of Cryptococcus neoformans Cell and Transcriptional Remodeling during Infection
de Freitas, G. J. C., Gouveia‐Eufrásio, L., Emídio, E. C. P., Carneiro, H. C. S., Baltazar, L. D. M., da Costa, M. C., Frasés, S., Araújo, G. R. D. S., da Paixão, T. A., Sossai, B. G., et al. (2022) · Cells · doi:10.3390/cells11233896 · Cited by 20
“In Candida albicans, hyphae are essential for tissue invasion, and yeast cells are crucial for hematogenous and lymphatic dissemination [13,14].”
BackgroundMehta, J., Borkhataria, C. H., Patel, A. I., et al. (2023) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-023-09742-5 · Cited by 18
“Multiple studies are reviewed, but it is still unclear how exactly candida cells manage to survive the blood environment’s challenges and escape from the blood-stream to produce chronic infections [2, 3].”
Lin, C., Lin, C.-N., Lin, C.-N., et al. (2014) · BMC Systems Biology · doi:10.1186/s12918-014-0116-0 · Cited by 18
“albicans to adapt to diverse environmental changes, including fluctuations in temperature, nutrients, and pH levels, renders it relatively difficult to treat in hosts [7].”
BackgroundKosalec, I., Ramić, S., Jelić, D., Antolović, R., Pepeljnjak, S., & Kopjar, N. (2011) · Archives of Industrial Hygiene and Toxicology · doi:10.2478/10004-1254-62-2011-2090 · Cited by 18
Synergistic Antifungal Activity of Berberine Derivative B-7b and Fluconazole
Li, L. P., Liu, W., Liu, H., Zhu, F., Zhang, D. Z., Shen, H., Xu, Z., Qi, Y. P., Zhang, S. Q., Chen, S. M., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126393 · Cited by 17
Zhao, S., Shang, A., Guo, M., Shen, L., Han, Y., & Huang, X. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1029966 · Cited by 17
Kaneko, Y., Ohno, H., Fukazawa, H., Murakami, Y., Imamura, Y., Kohno, S., & Miyazaki, Y. (2009) · Medical Mycology · doi:10.3109/13693780903426721 · Cited by 17
N,N′-diaryl-bishydrazones in a biphenyl platform: Broad spectrum antifungal agents
Chandrika, N. T., Dennis, E. K., Shrestha, S. K., Ngo, H., Green, K. D., Kwiatkowski, S., Deaciuc, A. G., Dwoskin, L. P., Watt, D. S., & Garneau‐Tsodikova, S. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.12.042 · Cited by 17
“The acid-catalyzed condensation of [1,1’-biphenyl]-3,4’-dicarboxaldehyde (4), [1,1’biphenyl]-4,4’-dicarboxaldehyde (5), or 4,4’-bisacetyl-1,1-biphenyl (6) with two equivalents of N-arylhydrazines at 80 °C furnished the N,N′-diarylbishydrazones 7–22 (Fig.”
BackgroundMethodWolf, J. M., & Davis, D. A. (2010) · Genetics · doi:10.1534/genetics.109.112029 · Cited by 17
“While C. albicans primarily causes non-life-threatening infections at these sites, life-threatening systemic infections can arise through escape of commensals from mucosal sites (Andrutis et al. 2000; Mavor et al. 2005).”
BackgroundPrieto-Granada, C. N., Lobo, A. Z. C., & Mihm, M. C. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-3429-2.00019-5 · Cited by 15
Juszczak, M., Zawrotniak, M., & Rąpała‐Kozik, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1295168 · Cited by 15
Urai, M., Kaneko, Y., Niki, M., Inoue, M., Tanabe, K., Umeyama, T., Fukazawa, H., Ohno, H., & Miyazaki, Y. (2014) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2014.06.004 · Cited by 14
Bellotti, D., Dudek, D., Rowińska‐Żyrek, M., & Remelli, M. (2018) · New Journal of Chemistry · doi:10.1039/c8nj00533h · Cited by 14
Small molecule based anti-virulence approaches against Candida albicans infections
Kalimuthu, S., Alshanta, O. A., Krishnamoorthy, A. L., Pudipeddi, A., Solomon, A. P., McLean, W., Leung, Y. Y., Ramage, G., & Neelakantan, P. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.2025337 · Cited by 13
“Thus indicating synergy and confirming the potential for a combinatory approach using MMV688768 and fluconazole in the clinical setting (Vila and Lopez-Ribot 2017).”
BackgroundSpecific Zn(II)-binding site in the C-terminus of Aspf2, a zincophore from Aspergillus fumigatus
Garstka, K., Hecel, A., Kozłowski, H., & Rowińska‐Żyrek, M. (2022) · Metallomics · doi:10.1093/mtomcs/mfac042 · Cited by 12
Lysine enhances the effect of amphotericin B against Candida albicans in vitro
Zhao, L., Jiang, J., Zhu, Z., Liao, Z., Yao, X., Yang, Y., Cao, Y., & Jiang, Y. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv125 · Cited by 13
“Candida albicans is the primary cause of systemic candidiasis, with a high mortality rate [2].”
BackgroundMadduri, M., Rudramurthy, S. M., & Roy, U. (2025) · Biofilm · doi:10.1016/j.bioflm.2025.100294 · Cited by 13
“In healthy individuals, however, they generally exist as commensal microbiota on the skin, genitals, or mucous membranes [1].”
From Attachment to Invasion: Infection Associated Genes of Candida albicans
Zakikhany, K., Thewes, S., Wilson, D., Martin, R., Albrecht, A., & Hube, B. (2008) · Nippon Ishinkin Gakkai Zasshi · doi:10.3314/jjmm.49.245 · Cited by 12
Self-citationGergondey, R., Garcia, C., Serre, V., Camadro, J., & Auchère, F. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.04.004 · Cited by 12
How the host fights against Candida infections
Richardson, M. D. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s24 · Cited by 12
Discovery and characterization of ß-1,6-glucan inhibitors
Kitamura, A. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2010.498472 · Cited by 11
“Then they invade the tissue by switching their growth from a unicellular growth form (yeast) to a multicellular, filamentous form (pseudohyphae or hyphae) with proteases degrading tissue barriers and destroying host defense molecules throughout the process [53].”
BackgroundFekete, A., Pócsi, I., Emri, T., Gyetvai, Á., Gazdag, Z., Pesti, M., Karányi, Z., Majoros, L., Gergely, L., & Pócsi, I. (2008) · Journal of Basic Microbiology · doi:10.1002/jobm.200800114 · Cited by 11
Nosocomial infections in acute leukemia: comparison between younger and elderly patients.
Fanci, R., Leoni, F., & Longo, G. (2008) · PubMed · Cited by 11
Bouterfas, K., Mehdadi, Z., Aouad, L., Elaoufi, M. M., Khaled, M. B., Latrèche, A., & Benchiha, W. (2016) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2016.02.019 · Cited by 11
Antifungal Effect of A Chimeric Peptide Hn-Mc against Pathogenic Fungal Strains
Kim, J., Park, S., Noh, G., Kim, H., Yoo, S., Kim, I. R., Lee, J. R., & Jang, M.-K. (2020) · Antibiotics · doi:10.3390/antibiotics9080454 · Cited by 11
“parapsilosis together are responsible for 50–90% of all cases of candidiasis, with a mortality rate of 40% among patients with opportunistic infections of pathogenic yeast in the skin, mucosa and intestinal tract of healthy individuals [2].”
BackgroundBroad‐Spectrum Antifungal Agents: Fluorinated Aryl‐ and Heteroaryl‐Substituted Hydrazones
Chandrika, N. T., Dennis, E. K., Brubaker, K. R., Kwiatkowski, S., Watt, D. S., & Garneau‐Tsodikova, S. (2020) · ChemMedChem · doi:10.1002/cmdc.202000626 · Cited by 13
Jagtap, S. S., Bedekar, A. A., & Rao, C. V. (2020) · ACS symposium series · doi:10.1021/bk-2020-1374.ch013 · Cited by 16
A Comprehensive Review of Identification Methods for Pathogenic Yeasts: Challenges and Approaches
Morovati, H., Kord, M., Ahmadikia, K., Eslami, S., Hemmatzadeh, M., Kurdestani, K. M., Khademi, M., & Darabian, S. (2023) · Advanced Biomedical Research · doi:10.4103/abr.abr_375_22 · Cited by 10
“such as diabetes, cancer, immunodeficiency, corticosteroids, broad‐spectrum antibiotic users, and organ transplants.[8,9]”
BackgroundHan, T., Qiu, M., Niu, X., wang, S., Wang, F., Cao, J., Tang, S., Cheng, L., Mei, Y., Liang, H., et al. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09360-7 · Cited by 10
“Although the blood brain barrier is made of specialized brain microvascular endothelial cells which are efficient in limiting the transcellular flux, C. albicans cells can cross brain microvascular endothelial cells in vitro, without affecting the monolayer integrity [22].”
BackgroundChu, S., Long, L. A., McCormick, T. S., Borroto–Esoda, K., Barat, S., & Ghannoum, M. A. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01989-20 · Cited by 9
Glass, K. A., Longley, S. J., Bliss, J. M., & Shaw, S. K. (2015) · Virulence · doi:10.1080/21505594.2015.1042643 · Cited by 9
“This clearance may represent a combination of adhesion or entrapment of fungi along blood vessel surfaces, as well as uptake by host phagocytic mechanisms.(16) Several families of adhesion molecules have been identified in C.”
BackgroundBypass of Dfi1 Regulation of Candida albicans Invasive Filamentation by Iron Limitation
Junier, A., Weeks, A., Alcaraz, Y., & Kumamoto, C. A. (2022) · mSphere · doi:10.1128/msphere.00779-21 · Cited by 7
“cans, including disseminated candidiasis (3).”
Chromatin Immunoprecipitation (ChIP) Assay in Candida albicans
Mitra, S., Rai, L. S., Chatterjee, G., & Sanyal, K. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3052-4_4 · Cited by 8
PEQUENO, M. A., SILVESTRE, M. R., Amêndola, I., Silva, C. R. G. E., Leão, M. V. P., & dos Santos, S. S. F. (2018) · RGO - Revista Gaúcha de Odontologia · doi:10.1590/1981-863720180002000033328 · Cited by 9
Granada, C. N. P., Lobo, A. Z. C., & Mihm, M. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44585-6.00020-5 · Cited by 9
Hamion, G., Aucher, W., Tardif, C., Miranda, J. M., Rouger, C., Imbert, C., & Girardot, M. (2022) · Antibiotics · doi:10.3390/antibiotics11111595 · Cited by 10
Caspofungin affects adhesion of Candida to a human cell line
Kyselgof, G., Sandovsky‐Losica, H., Berdicevsky, I., et al. (2007) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2006.12.003 · Cited by 8
Human Fungal Pathogens: Diversity, Genomics, and Preventions
Fahliyani, S. A., Rastegari, A. A., Yadav, N., & Yadav, A. N. (2021) · Fungal biology · doi:10.1007/978-3-030-60659-6_16 · Cited by 8
Bayot, J., Martin, C., Chevreux, G., Camadro, J., & Auchère, F. (2023) · Biochemical Journal · doi:10.1042/bcj20220505 · Cited by 8
Candida albicans cells exhibit media specific proteomic profiles during induction of filamentation
Legros, V., Albanèse, V., Chevreux, G., Camadro, J., & Auchère, F. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03627-4 · Cited by 7
Shen, M., Li, P., Wu, Y.-J., Lin, C., Chai, E., Chang, T., & Chen, C. (2019) · Medical Mycology · doi:10.1093/mmy/myz071 · Cited by 6
Paulovičová, E., Bystrický, S., Machová, E., & Bujdáková, H. (2008) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2008.00442.x · Cited by 7
Effective inactivation of Candida albicans biofilms by using supercritical carbon dioxide
Park, H. S., Yang, J., Choi, H. J., et al. (2015) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-015-1414-7 · Cited by 6
“In humans, this type of infection is known as candidiasis (or thrush) and can occur at sites such as the mouth, vagina, and intestine [1].”
BackgroundPendrak, M. L., Rodrigues, R. G., & Roberts, D. (2007) · Medical Mycology · doi:10.1080/13693780601164314 · Cited by 6
Karo, M. B., Hatta, M., Patellongi, I., et al. (2018) · Journal of Pharmacy & Pharmacognosy Research · doi:10.56499/jppres17.267_6.1.27 · Cited by 6
Systems Biology of Human-Pathogenic Fungi
Albrecht, D., & Guthke, R. (2009) · IGI Global eBooks · doi:10.4018/978-1-60566-076-9.ch024 · Cited by 6
Andrade-Pavón, D., Gómez‐García, O., & Villa‐Tanaca, L. (2024) · Journal of Fungi · doi:10.3390/jof10090629 · Cited by 10
“Whereas fungi of the genus Candida [7–9], especially Candida albicans [10–12], used to be the principal agent of hospital infections, in recent years, new multi-drug-resistant pathogens have emerged, such as C. auris, C. haemulonii [13–17], and non-Candida fungi (e.g., Aspergillus spp., Fusarium…”
BackgroundCandida Species Distribution of Clinical Specimens in Banda Aceh, Indonesia
Suhartono, S., Mahdani, W., Masthura, A., & Rusmana, İ. (2020) · Biosaintifika Journal of Biology & Biology Education · doi:10.15294/biosaintifika.v12i2.23758 · Cited by 6
“Candidiasis is still a major concern due to its increasing rate of infections ranging from superficially topical infections (Frías-De-León et al., 2019) to serious systemic infections (Mavor et al., 2005) in community as well as hospital settings.”
BackgroundInvasive candidiasis in dogs: A case report and review of the literature
Lorenzetti, D. M., Freitas, J. P., Mazaro, R. D., et al. (2024) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2024.101502 · Cited by 5
Y, S. T. A. (2014) · Pharmaceutical Regulatory Affairs Open Access · doi:10.4172/2167-7689.1000126 · Cited by 5
“Disseminated candidiasis is life-threatening and its prognosis is very poor [1-3].”
BackgroundQing, F., Sui, L., He, W., Chen, Y., Li, X., He, L., Xiao, Q., Guo, T., & Liu, Z. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300826 · Cited by 5
Jakab, Á., Antal, K., Kiss, Á., Emri, T., & Pócsi, I. (2014) · Folia Microbiologica · doi:10.1007/s12223-014-0305-7 · Cited by 4
Samaranayake, D., Atencio, D. P., Morse, R. H., Wade, J. T., Chaturvedi, V. P., & Hanes, S. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059094 · Cited by 5
Effects of hemin, CO2, and pH on the branching of Candida albicans filamentous forms
Jakab, Á., Antal, K., Emri, T., Boczonádi, I., Imre, A., Gebri, E., Majoros, L., Pfliegler, W. P., Szarka, M., Balla, G., et al. (2016) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/030.63.2016.023 · Cited by 4
Kiraz, N., Şen, S., Öz, Y., & Dağ, İ. (2022) · RENDICONTI LINCEI · doi:10.1007/s12210-022-01118-0 · Cited by 4
“Invasive fungal infections show high mortality rates, especially in immunocompromised individuals, and Candida species are responsible for both hospital-acquired and systemic infections (Mavor et al. 2005).”
BackgroundHemólise produzida por Candida tropicalis isoladas de amostras clínicas
de França, E. J. G., Fávero, D., Scremin, H., de Oliveira, M. T., Furlaneto-Maia, L., Quesada, R. M. B., & Furlaneto, M. C. (2010) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/s0037-86822010000300021 · Cited by 4
Synergistic anti-Candida effects of essential oil blends on biofilms at various maturation stages
Balázs, V. L., Puskár, L., Ormai, E., Farkas, Á., Utczás, M., Kocsis, B., Papp, N., Kerekes, E. B., Biró, V., & Kocsis, M. (2026) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2026.107515 · Cited by 3
Gupta, S., Nagar, L., Singla, M., Smriti, Singh, S. K., Gupta, G., Bhojraj, S., Syed, R. U., Alshammari, A., Alshammari, M. D., et al. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128362999250605093917 · Cited by 3
Tunç, B., Demiray, E., & Dereli, M. D. (2021) · Türk Mikrobiyoloji Cemiyeti Dergisi · doi:10.5222/tmcd.2021.84429 · Cited by 3
Pereira, P. A. T., Bini, D., Bovo, F., Faccioli, L. H., & Monteiro, M. C. (2016) · Folia Microbiologica · doi:10.1007/s12223-016-0443-1 · Cited by 3
Effect of a novel phyto‐compound on mucosal candidiasis: Further evidence from an ex vivo study
NAKAJIMA, J., PAPAAH, P., Yoshizawa, M., Marotta, F., NAKAJIMA, T., MIHARA, S., & Minelli, E. (2007) · Journal of Digestive Diseases · doi:10.1111/j.1443-9573.2007.00283.x · Cited by 3
Candida albicans Commensalism and Human Diseases
Chen, C., & Huang, X. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7534-1_10 · Cited by 4
Truong, T., Pang, L. M., Rajan, S., Wong, S. S. W., Fung, Y. M. E., Samaranayake, L. P., & Seneviratne, C. J. (2020) · Microorganisms · doi:10.3390/microorganisms8101541 · Cited by 4
“Candida albicans is a commensal polymorphic constituent fungus of the healthy oral microbiome of a majority of humans [1,2].”
BackgroundCharacterization of the beta-adrenoceptors in guinea-pig lung mast cells [proceedings].
van der Heijden, P. J., & Zaagsma, J. (1980) · PubMed Central · Cited by 3
Buchs, R., Lehner, B., Meuwly, P., & Schnyder, B. (2018) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2018.0042 · Cited by 2
Albakri, A. (2019) · Research and Review Insights · doi:10.15761/rri.1000151 · Cited by 2
“1000151 introduced into the patient’s body such as catheters, dental implants, endoprostheses, artificial joints or central nervous system (CNS) shunts [47,48].”
BackgroundAntifungal Resistance in Candida albicans
Seyedjavadi, S. S., Hatami, F., & Jahanshiri, Z. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1004578 · Cited by 3
O’Donnell, L. E., Robertson, D. P., & Ramage, G. (2015) · Springer eBooks · doi:10.1007/978-3-662-47194-4_2 · Cited by 3
Djimeli, C. L., Arfao, A. T., Ewoti, O. V. N., Bricheux, G., Nola, M., & Sime‐Ngando, T. (2014) · HAL · Cited by 2
Gene Expression during the Distinct Stages of Candidiasis
Wilson, D., Mayer, F. L., & Hube, B. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch18 · Cited by 2
Self-citationPärnänen, P. (2010) · Työväentutkimus Vuosikirja · Cited by 2
Baveloni, F. G., Martines, M. A. U., de Camargo, B. A. F., et al. (2026) · ACS Omega · doi:10.1021/acsomega.5c09016 · Cited by 1
Assessment of complement (C2&C4) in patients with recurrent candidal infections
Atallah, R. B., Hashem, O., El-Samea, H. S. A., et al. (2019) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2019.25812 · Cited by 1
Immunomodulatory Properties of Antifungal Agents on Immune Functions of the Host
Simitsopoulou, M., & Roilides, E. (2019) · Springer eBooks · doi:10.1007/978-1-4939-9034-4_53 · Cited by 1
Nelson, C. A., & Leventhal, J. S. (2024) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2024.12.008 · Cited by 1
Infectious Causes of Retinal Vasculitis: Causes, Presentation, Differentiation, and Therapy
Schlaen, A., Montoya, J., Heredia, M., et al. (2025) · Ophthalmologica · doi:10.1159/000545044 · Cited by 1
“Candida species are the most common cause of fungal endophthalmitis and belong to the yeast category [64, 65] (Table 2).”
Detection of Multidrug-Resistant Fungal Infections in Cancer Patients
Awasthi, K., Das, A., & Prasad, T. (2017) · Fungal biology · doi:10.1007/978-3-319-34106-4_16 · Cited by 1
Sinde, H., Patel, P., Kikani, K. M., Kothari, D. R., & Kikani, B. A. (2021) · Current Microbiology · doi:10.1007/s00284-021-02476-y · Cited by 1
“1 3 followed by penetration of the host tissues, a pivotal step for invasiveness of candidiasis [18].”
Background
Metadata
- Authors
- Mavor, A., Thewes, S., & Hube, B.
- Affiliations
- Robert Koch Institute (DE)
- Corresponding author
- Hube, B.
- ORCID
- Venue
- Current Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2005-12-01
- Volume
- 6
- Issue
- 8
- Pages
- 863-874
- ISSN
- 1389-4501 (ISSN-L)
- OpenAlex
- W2152663489
- Cited by
- 252
- References
- 0
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 11 · 2023: 9 · 2022: 11 · 2021: 18 · 2020: 15 · 2019: 15 · 2018: 8 · 2017: 9 · 2016: 16 · 2015: 18 · 2014: 15 · 2013: 14 · 2012: 9
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Drug Targets (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Robert Koch Institut
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- systemic candidiasis, Candida albicans, candidemia, invasive fungal infections, virulence factors, immunocompromised patients, opportunistic fungal pathogens, bloodstream infection, fungal pathogenesis, epidemiology
- MeSH terms
- Candida, Candidiasis, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
